BCR and co-receptor crosstalk facilitate the positive selection of self-reactive transitional B cells

Current Opinion in Immunology

Volumn 37, Issue , 2015, Pages 46-53

  Metzler, Genita ^a,b   Kolhatkar, Nikita S ^a,b   Rawlings, David J ^a,b  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b SEATTLE CHILDREN S RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B CELL ACTIVATING FACTOR RECEPTOR; B LYMPHOCYTE RECEPTOR; CD40 ANTIGEN; TOLL LIKE RECEPTOR; TRANSMEMBRANE ACTIVATOR AND CAML INTERACTOR; AUTOANTIGEN; LYMPHOCYTE ANTIGEN RECEPTOR;

ANTIBODY RESPONSE; AUTOIMMUNITY; CELL COMPARTMENTALIZATION; CELL POPULATION; CELL SELECTION; CELL SURVIVAL; HUMAN; IMMUNOLOGICAL TOLERANCE; LYMPHOCYTE PROLIFERATION; NONHUMAN; PRE B LYMPHOCYTE; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; REVIEW; SIGNAL TRANSDUCTION; ANIMAL; ANTIGEN MEDIATED CLONAL SELECTION; B LYMPHOCYTE; CELL DIFFERENTIATION; GENETICS; GERMINAL CENTER; IMMUNOLOGY; METABOLISM; MUTATION; PHYSIOLOGY;

ANIMALS; AUTOANTIGENS; AUTOIMMUNITY; B-LYMPHOCYTES; CELL DIFFERENTIATION; CLONAL SELECTION, ANTIGEN-MEDIATED; GERMINAL CENTER; HUMANS; MUTATION; RECEPTOR CROSS-TALK; RECEPTORS, ANTIGEN, B-CELL; SIGNAL TRANSDUCTION;

EID: 84947575849     PISSN: 09527915     EISSN: 18790372     Source Type: Journal    
DOI: 10.1016/j.coi.2015.10.001     Document Type: Review

References (52)

1. Hartley S.B., Crosbie J., Brink R., Kantor A.B., Basten A., Goodnow C.C. Elimination from peripheral lymphoid tissues of self-reactive B lymphocytes recognizing membrane-bound antigens. Nature 1991, 353:765-769.
2. Nemazee D. Receptor editing in lymphocyte development and central tolerance. Nat Rev Immunol 2006, 6:728-740.
3. Cambier J.C., Gauld S.B., Merrell K.T., Vilen B.J. B-cell anergy: from transgenic models to naturally occurring anergic B cells?. Nat Rev Immunol 2007, 7:633-643.
4. Lam K.P., Kühn R., Rajewsky K. In vivo ablation of surface immunoglobulin on mature B cells by inducible gene targeting results in rapid cell death. Cell 1997, 90:1073-1083.
5. Cancro M.P. Signalling crosstalk in B cells: managing worth and need. Nat Rev Immunol 2009, 9:657-661.
6. Srinivasan L., Sasaki Y., Calado D.P., Zhang B., Paik J.H., DePinho R.A., Kutok J.L., Kearney J.F., Otipoby K.L., Rajewsky K. PI3 kinase signals BCR-dependent mature B cell survival. Cell 2009, 139:573-586.
7. Khan W.N., Nilsson A., Mizoguchi E., Castigli E., Forsell J., Bhan A.K., Geha R., Sideras P., Alt F.W. Impaired B cell maturation in mice lacking Bruton's tyrosine kinase (Btk) and CD40. Int Immunol 1997, 9:395-405.
8. Sater R.A., Sandel P.C., Monroe J.G. B cell receptor-induced apoptosis in primary transitional murine B cells: signaling requirements and modulation by T cell help. Int Immunol 1998, 10:1673-1682.
9. Chen Z., Shojaee S., Buchner M., Geng H., Lee J.W., Klemm L., Titz B., Graeber T.G., Park E., Tan Y.X., et al. Signalling thresholds and negative B-cell selection in acute lymphoblastic leukaemia. Nature 2015, 521:357-361.
10. Zikherman J., Parameswaran R., Weiss A. Endogenous antigen tunes the responsiveness of naive B cells but not T cells. Nature 2012, 489:160-164.
11. Gu H. Most peripheral B cells in mice are ligand selected. J Exp Med 1991, 173:1357-1371.
12. Meyer-Bahlburg A., Andrews S.F., Yu K.O.A., Porcelli S.A., Rawlings D.J. Characterization of a late transitional B cell population highly sensitive to BAFF-mediated homeostatic proliferation. J Exp Med 2008, 205:155-168.
13. Freitas A.A., Rosado M.M., Viale A.C., Grandien A. The role of cellular competition in B cell survival and selection of B cell repertoires. Eur J Immunol 1995, 25:1729-1738.
14. Cancro M.P., Kearney J.F. B cell positive selection: road map to the primary repertoire?. J Immunol 2004, 173:15-19.
15. Mackay F., Schneider P. Cracking the BAFF code. Nat Rev Immunol 2009, 9:491-502.
16. Cremasco V., Woodruff M.C., Onder L., Cupovic J., Nieves-Bonilla J.M., Schildberg F.A., Chang J., Cremasco F., Harvey C.J., Wucherpfennig K., et al. B cell homeostasis and follicle confines are governed by fibroblastic reticular cells. Nat Immunol 2014, 15:973-981.
17. Fairfax K.A., Tsantikos E., Figgett W.A., Vincent F.B., Quah P.S., Lepage M., Hibbs M.L., Mackay F. BAFF-driven autoimmunity requires CD19 expression. J Autoimmun 2015, 62:1-10.
18. Otipoby K.L., Sasaki Y., Schmidt-Supprian M., Patke A., Gareus R., Pasparakis M., Tarakhovsky A., Rajewsky K. BAFF activates Akt and Erk through BAFF-R in an IKK1-dependent manner in primary mouse B cells. Proc Natl Acad Sci U S A 2008, 105:12435-12438.
19. Brightbill H.D., Jackman J.K., Suto E., Kennedy H., Jones C., Chalasani S., Lin Z., Tam L., Roose-Girma M., Balázs M., et al. Conditional deletion of NF-κB-inducing kinase (NIK) in adult mice disrupts mature B cell survival and activation. J Immunol 2015, 195:953-964.
20. Schweighoffer E., Vanes L., Nys J., Cantrell D., McCleary S., Smithers N., Tybulewicz V.L.J. The BAFF receptor transduces survival signals by co-opting the B cell receptor signaling pathway. Immunity 2013, 38:475-488.
21. Hobeika E., Levit-Zerdoun CD19 and BAFF-R can signal to promote B-cell survival in the absence of Syk. EMBO J 2015, 34:838-840.
22. Almaden J.V., Tsui R., Liu Y.C., Birnbaum H., Shokhirev M.N., Ngo K.A., Davis-Turak J.C., Otero D., Basak S., Rickert R.C., et al. A pathway switch directs BAFF signaling to distinct NFkB transcription factors in maturing and proliferating B cells. Cell Rep 2014, 9:2098-2111.
23. Moisini I., Davidson A. BAFF: a local and systemic target in autoimmune diseases. Clin Exp Immunol 2009, 158:155-163.
24. Thien M., Phan T.G., Gardam S., Amesbury M., Basten A., Mackay F., Brink R. Excess BAFF rescues self-reactive B cells from peripheral deletion and allows them to enter forbidden follicular and marginal zone niches. Immunity 2004, 20:785-798.
25. Lesley R., Xu Y., Kalled S.L., Hess D.M., Schwab S.R., Shu H.-B., Cyster J.G. Reduced competitiveness of autoantigen-engaged B cells due to increased dependence on BAFF. Immunity 2004, 20:441-453.
26. Figgett W.A., Deliyanti D., Fairfax K.A., Quah P.S., Wilkinson-Berka J.L., Mackay F. Deleting the BAFF receptor TACI protects against systemic lupus erythematosus without extensive reduction of B cell numbers. J Autoimmun 2015, 61:9-16.
27. Hostager B.S., Bishop G.A. CD40-mediated activation of the NF-κB2 pathway. Front Immunol 2013, 4.
28. Lesley R., Kelly L.M., Xu Y., Cyster J.G. Naive CD4 T cells constitutively express CD40L and augment autoreactive B cell survival. Proc Natl Acad Sci U S A 2006, 103:10717-10722.
29. Herve M., Isnardi I., Ng Y.S., Bussel J.B., Ochs H.D., Cunningham-Rundles C., Meffre E. CD40 ligand and MHC class II expression are essential for human peripheral B cell tolerance. J Exp Med 2007, 204:1583-1593.
30. Schwartz M.A., Kolhatkar N.S., Thouvenel C., Khim S., Rawlings D.J. CD4+ T cells and CD40 participate in selection and homeostasis of peripheral B cells. J Immunol 2014, 193:3492-3502.
31. Menard L., Saadoun D., Isnardi I., Ng Y.-S., Meyers G., Massad C., Price C., Abraham C., Motaghedi R., Buckner J.H., et al. The PTPN22 allele encoding an R620W variant interferes with the removal of developing autoreactive B cells in humans. J Clin Invest 2011, 121:3635-3644.
32. Dai X., James R.G., Habib T., Singh S., Jackson S., Khim S., Moon R.T., Liggitt D., Wolf-Yadlin A., Buckner J.H., et al. A disease-associated PTPN22 variant promotes systemic autoimmunity in murine models. J Clin Invest 2013, 123:2024-2036.
33. Rawlings D.J., Dai X., Buckner J.H. The role of PTPN22 risk variant in the development of autoimmunity: finding common ground between mouse and human. J Immunol 2015, 194:2977-2984.
34. Jackson S.W., Kolhatkar N.S., Rawlings D.J. B cells take the front seat: dysregulated B cell signals orchestrate loss of tolerance and autoantibody production. Curr Opin Immunol 2015, 33C:70-77.
35. Suurmond J., Diamond B. Autoantibodies in systemic autoimmune diseases: specificity and pathogenicity. J Clin Invest 2015, 125:2194-2202.
36. Chaturvedi A., Dorward D., Pierce S.K. The B cell receptor governs the subcellular location of toll-like receptor 9 leading to hyperresponses to DNA-containing antigens. Immunity 2008, 28:799-809.
37. Chaturvedi A., Pierce S.K. How location governs toll-like receptor signaling. Traffic 2009, 10:621-628.
38. Miles K., Heaney J., Sibinska Z., Salter D., Savill J., Gray D., Gray M. A tolerogenic role for Toll-like receptor 9 is revealed by B-cell interaction with DNA complexes expressed on apoptotic cells. Proc Natl Acad Sci U S A 2012, 109:887-892.
39. Isnardi I., Ng Y.-S., Srdanovic I., Motaghedi R., Rudchenko S., Bernuth von H., Zhang S.-Y., Puel A., Jouanguy E., Picard C., et al. IRAK-4- and MyD88-dependent pathways are essential for the removal of developing autoreactive B cells in humans. Immunity 2008, 29:746-757.
40. Desnues B., Macedo A.B., Roussel-Queval A., Bonnardel J., Henri S., Demaria O., Alexopoulou L. TLR8 on dendritic cells and TLR9 on B cells restrain TLR7-mediated spontaneous autoimmunity in C57BL/6 mice. Proc Natl Acad Sci U S A 2014, 111:1497-1502.
41. Mills R.E., Lam V.C., Tan A., Cresalia N., Oksenberg N., Zikherman J., Anderson M., Weiss A., Hermiston M.L. Unbiased modifier screen reveals that signal strength determines the regulatory role murine TLR9 plays in autoantibody production. J Immunol 2015, 194:3675-3686.
42. Becker-Herman S., Meyer-Bahlburg A., Schwartz M.A., Jackson S.W., Hudkins K.L., Liu C., Sather B.D., Khim S., Liggitt D., Song W., et al. WASp-deficient B cells play a critical, cell-intrinsic role in triggering autoimmunity. J Exp Med 2011, 208:2033-2042.
43. Jackson S.W., Scharping N.E., Kolhatkar N.S., Khim S., Schwartz M.A., Li Q.Z., Hudkins K.L., Alpers C.E., Liggitt D., Rawlings D.J. Opposing impact of B cell-intrinsic TLR7 and TLR9 signals on autoantibody repertoire and systemic inflammation. J Immunol 2014, 192:4525-4532.
44. Kolhatkar N.S., Brahmandam A., Thouvenel C.D., Becker-Herman S., Jacobs H.M., Schwartz M.A., Allenspach E.J., Khim S., Panigrahi A.K., Luning Prak E.T., et al. Altered BCR and TLR signals promote enhanced positive selection of autoreactive transitional B cells in Wiskott-Aldrich syndrome. J Exp Med 2015, 208:2033.
45. Maranhão A.Q., Costa M.B.W., Guedes L., Moraes-Vieira P.M., Raiol T., Brigido M.M. A mouse variable gene fragment binds to DNA independently of the BCR context: a possible role for immature B-cell repertoire establishment. PLoS ONE 2013, 8:e72625.
46. Brigido M.M., Polymenis M., Stollar B.D. Role of mouse VH10 and VL gene segments in the specific binding of antibody to Z-DNA, analyzed with recombinant single chain Fv molecules. J Immunol 1993, 150:469-479.
47. Richardson C., Chida A.S., Adlowitz D., Silver L., Fox E., Jenks S.A., Palmer E., Wang Y., Heimburg-Molinaro J., Li Q.-Z., et al. Molecular basis of 9G4 B cell autoreactivity in human systemic lupus erythematosus. J Immunol 2013, 191:4926-4939.
48. Jenks S.A., Palmer E.M., Marin E.Y., Hartson L., Chida A.S., Richardson C., Sanz I. 9G4+ autoantibodies are an important source of apoptotic cell reactivity associated with high levels of disease activity in systemic lupus erythematosus. Arthritis Rheum 2013, 65:3165-3175.
49. Bhat N.M., Kshirsagar M.A., Bieber M.M., Teng N.N.H. IgG subclasses and isotypes of VH4-34 encoded antibodies. Immunol Invest 2015, 44:400-410.
50. Pugh-Bernard A.E., Silverman G.J., Cappione A.J., Villano M.E., Ryan D.H., Insel R.A., Sanz I. Regulation of inherently autoreactive VH4-34 B cells in the maintenance of human B cell tolerance. J Clin Invest 2001, 108:1061-1070.
51. Tipton C., Fucile C.F., Darce J., Ichikawa T., Gregoretti I., Schieferi S., Horn J., Jenks S.A., Feldman R.J., Mehr R., et al. Diversity, cellular origin and autoreactivity of antibody-secreting cell expansions in acute SLE. Nat Immunol 2015.
52. Medgyesi D., Hobeika E., Biesen R., Kollert F., Taddeo A., Voll R.E., Hiepe F., Reth M. The protein tyrosine phosphatase PTP1B is a negative regulator of CD40 and BAFF-R signaling and controls B cell autoimmunity. J Exp Med 2014, 211:427-440.